Literature DB >> 17553816

Relation of body mass index (BMI) to disease free (DFS) and distant disease free survivals (DDFS) among Turkish women with operable breast carcinoma.

Binnaz Demirkan1, Ahmet Alacacioglu, Ugur Yilmaz.   

Abstract

BACKGROUND: The correlation between body mass index (BMI) and patient and tumor characteristics related to prognosis has not been well explored and may help to elucidate the mechanisms involved in the carcinogenesis. Because of the equivocal, inconsistent and uncertain research results as well as racial and ethnic differences, we aimed to evaluate the prognostic significance of high BMI in Turkish women with operable breast carcinoma.
METHODS: Two hundred and sixty-six patients who had operable invasive breast carcinoma diagnosed from 2000 through 2004 in a single institution were evaluated for their demographic features, BMI, histopathological/immunohistochemical examinations and treatments. Quetelet BMI [weight (kg)/height (m)2] categories were selected according to the World Health Organization definition. Disease free survival (DSF) as well as distant disease free survival (DDSF) analyses were performed to identify independent prognostic factors.
RESULTS: Post-menopausal patients were significantly in the higher quartile of BMI than pre-menopausal patients (P = 0.003). While post-menopausal obese patients had worse DSF and DDFS (P = 0.001), vascular invasion was the independent prognostic factor for both survival indices (P = 0.031).
CONCLUSIONS: Post-menopausal obese Turkish women are at increased risk of developing breast tumors with aggressive phenotype and obesity is a strong predictor of poor DSF and DDFS. Preventive strategies to reduce not only the prevalence of obesity and breast cancer but also the mortality must be recognized as the cost-effective public-health policy for Turkey.

Entities:  

Mesh:

Year:  2007        PMID: 17553816     DOI: 10.1093/jjco/hym023

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  11 in total

Review 1.  The obesity-inflammation-eicosanoid axis in breast cancer.

Authors:  Linda Vona-Davis; David P Rose
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-30       Impact factor: 2.673

2.  Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study.

Authors:  Clinton Yam; Francisco J Esteva; Miral M Patel; Akshara S Raghavendra; Naoto T Ueno; Stacy L Moulder; Kenneth R Hess; Girish S Shroff; Silvia Hodge; Kimberly H Koenig; Mariana Chavez Mac Gregor; Robin L Griner; Sai-Ching J Yeung; Gabriel N Hortobagyi; Vicente Valero
Journal:  Invest New Drugs       Date:  2019-01-05       Impact factor: 3.850

Review 3.  Minireview: Obesity and breast cancer: the estrogen connection.

Authors:  Margot P Cleary; Michael E Grossmann
Journal:  Endocrinology       Date:  2009-04-16       Impact factor: 4.736

4.  Obesity and Prognostic Variables in Colombian Breast Cancer Patients: A Cross-Sectional Study.

Authors:  Javier Cuello-López; Ana Fidalgo-Zapata; Elsa Vásquez-Trespalacios
Journal:  Int J Breast Cancer       Date:  2017-05-18

5.  Female Body Mass Index and its Relationship With Triple Negative Breast Cancer and Ethnicity.

Authors:  Khurram Bilal Tariq; Fauzia Rana
Journal:  World J Oncol       Date:  2013-09-27

6.  Associations between body mass index and molecular subtypes as well as other clinical characteristics of breast cancer in Chinese women.

Authors:  Fei-Yu Chen; Hui-Ying Ou; Shou-Man Wang; Yu-Hui Wu; Guo-Jiao Yan; Li-Li Tang
Journal:  Ther Clin Risk Manag       Date:  2013-03-26       Impact factor: 2.423

7.  Assessment of Factors Associated with Breast Self-Examination among Health Extension Workers in West Gojjam Zone, Northwest Ethiopia.

Authors:  Muluken Azage; Gedefaw Abeje; Alemtsehay Mekonnen
Journal:  Int J Breast Cancer       Date:  2013-11-05

8.  Breast cancer pathology, receptor status, and patterns of metastasis in a rural appalachian population.

Authors:  Linda Vona-Davis; David P Rose; Vijaya Gadiyaram; Barbara Ducatman; Gerald Hobbs; Hannah Hazard; Sobha Kurian; Jame Abraham
Journal:  J Cancer Epidemiol       Date:  2014-01-09

9.  Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.

Authors:  Ye Won Jeon; Su Hwan Kang; Min Ho Park; Woosung Lim; Se Heun Cho; Young Jin Suh
Journal:  BMC Cancer       Date:  2015-11-06       Impact factor: 4.430

10.  Association between body mass index and clinical characteristics, as well as with management, in Chinese patients with breast cancer.

Authors:  Bin Wang; Lizhe Zhu; Siyuan Jiang; Lizhi Zhao; Yuhui Zhou; Ligang Niu; Yu Yan; Ke Wang
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.